Compugen Ltd. (Nasdaq: CGEN), a clinical-stage therapeutic discovery and development company, announced on Monday that it has named Alberto Sessa as its new cief financial officer (CFO) and member of the management team effective 1 November 2022.

Alberto has over 30 years of industry experience serving in public and private companies. He has served as an acting CFO at several startup companies in the high-tech industry. He has also held the position of CFO at Allot, and served as Worldwide Group CFO at Amdocs.

Anat Cohen-Dayag, Ph.D., president, and CEO of Compugen, said, 'I am delighted to have a financial executive of Alberto's expertise and experience join Compugen and strengthen our management team. His extensive experience and track record in leading financing, investor relations, M&A, and business development transactions and providing strategic financial direction to grow companies, will be invaluable as we accelerate towards our strategic ambitions and deliver value to our stakeholders including patients and shareholders.'